OCR Text |
Show 300 LITERATURE ABSTRACTS Management of Strabismus with Botulinum A Toxin. Biglan AW, Burnstine RA, Rogers GL, Saunders RA. Ophthalmology 1989; 96: 935- 43 Guly). [ Reprint requests to Dr. A. W. Biglan, 3518 Fifth Ave., Pittsburgh, PA 15213- 3388.] These reports concern the use of botulinum A toxin to correct strabismus in children. In the first article, a 2- 5- year follow- up of previously reported children showed a very good long- term response in the 62 who were available for the study. The second article reports 153 children followed for at least 6 months but most for 1- 2 years after treatment, and their results were more pessimistic. These somewhat contrasting articles are of interest to those who would like to treat strabismic children with botulinum. Lyn A. Sedwick, M. D. Primary Orbital Neuroblastoma. Bullock JD, Goldberg SH, Rakes SM, Felder OS, Connelly PJ. Arch OphthalmoI1989; 107: 1031- 3 Guly). [ Reprint requests to Dr. J. D. Bullock, Department of Ophthalmology, Wright State University School of Medicine, Plumwood Bldg., Suite 230, 5 Plumwood Rd., Dayton, OH 45409.] A 35- year- old man is discussed who had surgical removal of an orbital mass that proved to be a neuroblastoma. There has been only one other report of a primary orbital neuroblastoma, according to the authors. Lyn A. Sedwick, M. D. Orbital Optic Nerve Glioma in Adult Life. Wule AE, Bergin OJ, Barnes 0, Scaravilli F, Wright JE, McDonald WI. Arch Ophthalmol 1989; 107: 1013- 6 Guly). [ Reprint requests to Dr. A. E. Wule, Oculoplastic/ Orbital Service, Sheie Eye Institute, 51 N. 39th St., Philadelphia, PA 19104.] The authors report seven adults, aged 18- 61 years, with optic nerve glioma, some with chiasmal involvement, all of whom had surgery performed. Based on their favorable experience with the tumors, they recommend a conservative approach. Only when all useful vision in the eye is lost would they operate for total removal of the glioma and optic nerve. If circumstances warrant, radiation therapy can be tried, although they readily admit that its efficacy is not yet established. Lyn A. Sedwick, M. D. Methylprednisolone Pulse Therapy in Severe Dysthyroid Optic Neuropathy. Guy JR, Fagien S, Donovan JP, Rubin ML. Ophthalmology 1989; 96: 1048- 53 Guly). [ Reprint requests to Dr. J. R. Guy, Neuro- ophthalmology Service, Box J- 284, JHMHC, University of Florida, College of Medicine, Gainesville, FL 32610- 0284.] Five patients were treated with intravenous high- dose methylprednisolone therapy for unilateral or bilateral visual loss from thyroid ophthalmopathy. Only one was first tried on oral steroids, and three of five had significant adverse effects of therapy ( hypertension, tachycardia) which were easily controlled. Dr. Steven Feldon discusses this article, pointing out the shortcomings of the study but concluding that he was " impressed enough with the preliminary results . . . to consider the use of pulse methylprednisolone therapy in my patients with Graves' - related optic neuropathy when oral corticosteroids seem ineffective." Lyn A. Sedwick, M. D. Computed Tomographic Features of Nonthyroid Extraocular Muscle Enlargement. Patrinely JR, Osborn AG, Anderson RL, Whiting AS. Ophthalmology 1989; 96: 1038- 47 ( July). [ Reprint requests to Dr. J. R. Patrinely, Cullen Eye Institute, Baylor College of Medicine, 6501 Fannin St., Houston, TX 77030.] This article has been waiting to be written since the advent of high- resolution computerized tomographic scanning. I thank the authors for an excellent reference. A wealth of disorders are discussed and illustrated, with representative computerized tomographic scans and summaries of salient features in their cases. The only criticism I have is that 10 more pages of their actual computerized tomographic scan pictures would have been a wonderful extension of this article. Share this article with your favorite neuroradiologist. Lyn A. Sedwick. ,\ 1 D. |